Rep. Julie Johnson Sells Procter & Gamble Company (The) (NYSE:PG) Stock

Representative Julie Johnson (D-Texas) recently sold shares of Procter & Gamble Company (The) (NYSE:PG). In a filing disclosed on January 15th, the Representative disclosed that they had sold between $1,001 and $15,000 in Procter & Gamble stock on December 18th. The trade occurred in the Representative’s “CHASE BROKERAGE ACCOUNT (3935)” account.

Representative Julie Johnson also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Texas Instruments (NASDAQ:TXN) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of UnitedHealth Group (NYSE:UNH) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of General Dynamics (NYSE:GD) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of PepsiCo (NASDAQ:PEP) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of Dover (NYSE:DOV) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of Philip Morris International (NYSE:PM) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of Johnson & Johnson (NYSE:JNJ) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of Bank of America (NYSE:BAC) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of Walmart (NASDAQ:WMT) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of Republic Services (NYSE:RSG) on 12/18/2025.

Procter & Gamble Stock Down 0.1%

Shares of NYSE:PG traded down $0.08 during mid-day trading on Friday, hitting $144.55. 11,518,068 shares of the company traded hands, compared to its average volume of 9,217,492. The firm’s 50 day simple moving average is $144.72 and its 200 day simple moving average is $150.91. The firm has a market cap of $337.77 billion, a P/E ratio of 21.10, a PEG ratio of 4.88 and a beta of 0.39. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.51 and a current ratio of 0.71. Procter & Gamble Company has a 52-week low of $137.62 and a 52-week high of $179.99.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, October 24th. The company reported $1.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.09. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The company had revenue of $22.39 billion during the quarter, compared to the consensus estimate of $22.23 billion. During the same quarter last year, the company earned $1.93 earnings per share. Procter & Gamble’s revenue for the quarter was up 3.0% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. On average, equities analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, February 17th. Stockholders of record on Friday, January 23rd will be paid a $1.0568 dividend. The ex-dividend date is Friday, January 23rd. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.9%. Procter & Gamble’s dividend payout ratio (DPR) is 61.75%.

Insiders Place Their Bets

In other Procter & Gamble news, CAO Matthew W. Janzaruk sold 725 shares of the firm’s stock in a transaction on Thursday, October 30th. The stock was sold at an average price of $149.57, for a total value of $108,438.25. Following the sale, the chief accounting officer directly owned 979 shares in the company, valued at approximately $146,429.03. This trade represents a 42.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.20% of the stock is owned by corporate insiders.

Key Stories Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: P&G announced a dividend increase that pushed shares higher after the news; investors often view dividend raises as a sign of cash-flow confidence. Procter & Gamble (NYSE:PG) Shares Up 1.4% Following Dividend Announcement
• Positive Sentiment: UBS reiterated a Buy rating on PG, which can lend support to the stock by reinforcing institutional conviction. UBS Sticks to Their Buy Rating for Procter & Gamble (PG)
• Positive Sentiment: Dividend-focused coverage included P&G in a roundup of high-yield and dividend-resilient names, reinforcing interest from income-oriented investors. Dividend roundup: Goldman Sachs, Procter & Gamble, Costco, Caterpillar, and more
• Neutral Sentiment: Zacks published an in-depth preview of Q2 metrics (beyond EPS/revenue), offering models and expectations investors should watch when the quarter posts—useful for positioning but not an immediate catalyst. Insights Into P&G (PG) Q2: Wall Street Projections for Key Metrics
• Neutral Sentiment: The options market shows unusual activity that some interpret as signaling bigger moves ahead; this is mixed info—could indicate hedging or directional bets. Is the Options Market Predicting a Spike in Procter & Gamble Stock?
• Neutral Sentiment: P&G is scheduled to report earnings soon (projected posting), keeping the stock sensitive to the quarter’s top-line and margin details. Procter & Gamble (PG) Projected to Post Earnings on Thursday
• Neutral Sentiment: A comparative profile vs. smaller peer Synergy CHC was published; not directly market-moving for PG but helpful context for sector/peer analysis. Head to Head Comparison: Procter & Gamble (NYSE:PG) vs. Synergy CHC (NASDAQ:SNYR)
• Neutral Sentiment: P&G appears on lists of dividend-paying Dow stocks (Dogs of the Dow coverage), which can attract income-focused flows over time but is not an immediate catalyst. The Dogs of the Dow: 10 Downtrodden Dividends Paying Out Up to 6.8%
• Neutral Sentiment: Media noted that CEO stock incentives could meaningfully increase his compensation—this aligns management with shareholders but may raise questions about dilution/compensation structure for some investors. Procter & Gamble CEO could see major wealth boost from stock incentives
• Negative Sentiment: Zacks’ earnings preview warned Q2 EPS may decline and suggested P&G may lack the mix for an earnings beat—this raises short-term downside risk if results disappoint. Earnings Preview: Procter & Gamble (PG) Q2 Earnings Expected to Decline
• Negative Sentiment: Large put buying was reported (76,923 puts), a roughly 190% jump vs. typical volume—this is a bearish options signal that could amplify volatility or signal hedging against a near-term drop. Is the Options Market Predicting a Spike in Procter & Gamble Stock?
• Negative Sentiment: A report noted an insider (Rep. Gilbert Ray Cisneros, Jr.) sold shares; insider selling can be perceived negatively even if non-material. Procter & Gamble (NYSE:PG) Stock Unloaded Rep. Gilbert Ray Cisneros, Jr.

Analyst Ratings Changes

PG has been the topic of several analyst reports. Bank of America dropped their price target on shares of Procter & Gamble from $180.00 to $174.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. Weiss Ratings restated a “hold (c)” rating on shares of Procter & Gamble in a report on Monday, December 29th. UBS Group cut their target price on Procter & Gamble from $176.00 to $161.00 and set a “buy” rating on the stock in a research report on Wednesday. Piper Sandler assumed coverage on shares of Procter & Gamble in a research note on Wednesday, January 7th. They issued a “neutral” rating and a $150.00 price target for the company. Finally, Wells Fargo & Company cut their price target on shares of Procter & Gamble from $170.00 to $158.00 and set an “overweight” rating on the stock in a report on Monday, January 5th. Fifteen investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $168.36.

Institutional Trading of Procter & Gamble

Institutional investors have recently added to or reduced their stakes in the business. Lantz Financial LLC raised its stake in Procter & Gamble by 1.2% during the second quarter. Lantz Financial LLC now owns 5,237 shares of the company’s stock worth $834,000 after acquiring an additional 64 shares during the period. Orca Investment Management LLC raised its position in shares of Procter & Gamble by 2.0% during the 2nd quarter. Orca Investment Management LLC now owns 3,238 shares of the company’s stock worth $516,000 after purchasing an additional 64 shares during the period. Silver Oak Securities Incorporated raised its position in shares of Procter & Gamble by 0.3% during the 2nd quarter. Silver Oak Securities Incorporated now owns 22,118 shares of the company’s stock worth $3,524,000 after purchasing an additional 65 shares during the period. Access Financial Services Inc. boosted its position in Procter & Gamble by 0.6% during the 2nd quarter. Access Financial Services Inc. now owns 10,889 shares of the company’s stock valued at $1,735,000 after purchasing an additional 65 shares during the period. Finally, Sovereign Financial Group Inc. boosted its position in Procter & Gamble by 1.1% during the 2nd quarter. Sovereign Financial Group Inc. now owns 5,823 shares of the company’s stock valued at $928,000 after purchasing an additional 65 shares during the period. Institutional investors own 65.77% of the company’s stock.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas’ 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

Johnson (Democratic Party) ran for election to the U.S. House to represent Texas’ 32nd Congressional District. She won in the general election on November 5, 2024.

Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson’s career experience includes working as an attorney.

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.